The chemical structure of bardoxolone methyl. | Download Scientific Diagram
Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney | American Society of Nephrology
Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl - Journal of Cardiac Failure
Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells | Molecular Pharmacology
Frontiers | Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies
FB15804 | 218600-53-4 | Bardoxolone methyl | Biosynth Carbosynth
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes | NEJM
Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram
Bardoxolone methyl: drug development for diabetic kidney disease | SpringerLink
Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
Increased albuminuria in bardoxolone methyl–treated type 2 diabetes patients: mere reflection of eGFR improvement? - Kidney International
Frontiers | Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages
Molecules | Free Full-Text | Transcription Factors as Therapeutic Targets in Chronic Kidney Disease | HTML
Bardoxolone methyl: drug development for diabetic kidney disease | SpringerLink
Bardoxolone Methyl | ≥99%(HPLC) | Selleck | IκB/IKK inhibitor
BARDOXOLONE METHYL
Antioxidants | Free Full-Text | Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling | HTML
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect
Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its | DDDT
Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Imp
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites | Journal of Medicinal Chemistry
Targeting crosstalk between Nrf-2, NF-κB and androgen receptor signaling in prostate cancer
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy
Bardoxolone methyl (RTA 402) | Nrf2 Activator | MedChemExpress
